Portfolio comparison
Genentech Inc vs Dexcom
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Genentech Inc
Patents indexed
13
Year range
1982 – 2017
Most recent
2017
biotechpharmaceuticalgene_editinghealthcareoncology
Top Patents13 enriched
US 4816567· 1989
Making Hybrid Antibodies from Different Animals
US 7527791· 2009
How Engineered Antibodies Target TGF-beta Proteins to Fight Cancer
US 6054297· 2000
How to Redesign Mouse Antibodies for Safe Use in Humans
Activity by Decade
1980s2
2000s8
2010s3
Company B
Dexcom
Patents indexed
3
Year range
2016 – 2022
Most recent
2022
softwarebiotechtelecommunicationsconsumer_electronicsmedical_devices
Top Patents3 enriched
US 9282925· 2016
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
US 11382539· 2022
A Catheter That Measures Glucose While Delivering Medication
US 20230263439
How a Sensor Checks Itself for Accuracy Using Other Body Data
Activity by Decade
2010s1
2020s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.